Adviser Profile

Exempt Reporting Adviser

2B(3)- PF>150mn act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2) because you have assets under management, as defined in rule 203(m)-1, in the United States of $150 million or more

Private Fund GAV* 0 -100%
SMA’s No
Private Funds 0 1

Private Funds

Employees

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker92337C203 Stock NameVERASTEM INC $ Position$12,795,575 % Position7.00% $ Change-27.00% # Change1.00%
Stck Ticker30052C107 Stock NameEVOLUS INC $ Position$11,035,724 % Position6.00% $ Change53.00% # Change-10.00%
Stck Ticker640268306 Stock NameNEKTAR THERAPEUTICS $ Position$8,422,856 % Position5.00% $ Change38.00% # Change42.00%
Stck Ticker88032L605 Stock NameTENAX THERAPEUTICS INC $ Position$9,603,000 % Position5.00% $ Change-38.00% # Change-32.00%
Stck Ticker000899104 Stock NameADMA BIOLOGICS INC (CALL) $ Position$7,950,000 % Position4.00% $ Change-23.00% # Change-43.00%
Stck Ticker000899104 Stock NameADMA BIOLOGICS INC $ Position$6,193,800 % Position3.00% $ Change-7.00% # Change0.00%
Stck Ticker29014R301 Stock NameELOXX PHARMACEUTICALS INC $ Position$5,512,581 % Position3.00% $ Change # Change
Stck Ticker13463J101 Stock NameCAMP4 THERAPEUTICS CORP $ Position$6,072,648 % Position3.00% $ Change-1.00% # Change0.00%
Stck Ticker457669307 Stock NameINSMED INC (CALL) $ Position$5,600,000 % Position3.00% $ Change # Change
Stck Ticker48669G303 Stock NameKAZIA THERAPEUTICS LTD $ Position$4,860,120 % Position3.00% $ Change89.00% # Change0.00%